Treating obesity using glucagon-like peptide-1-directed N-methyl-D-aspartate receptor inhibition Post author: Post published:May 20, 2024 Post category:uncategorized Bimodal drug that successfully cures obesity, hyperglycemia, and dyslipidemia in mouse models. You Might Also Like Study reveals doubling of chronic hypertension in pregnancy from 2008 to 2021 in the U. S. June 17, 2024 Sapio Sciences and Zifo announce strategic partnership July 31, 2024 Scientists find link between bacterium in the gut ecosystem and lupus June 26, 2026
Study reveals doubling of chronic hypertension in pregnancy from 2008 to 2021 in the U. S. June 17, 2024